Janux Therapeutics, Inc. (JANX) News

Janux Therapeutics, Inc. (JANX): $50.55

1.31 (-2.53%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

C

Add JANX to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#116 of 362

in industry

Filter JANX News Items

JANX News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

JANX News Highlights

  • For JANX, its 30 day story count is now at 2.
  • Over the past 26 days, the trend for JANX's stories per day has been choppy and unclear. It has oscillated between 1 and 1.

Latest JANX News From Around the Web

Below are the latest news stories about JANUX THERAPEUTICS INC that investors may wish to consider to help them evaluate JANX as an investment opportunity.

An Intrinsic Calculation For Janux Therapeutics, Inc. (NASDAQ:JANX) Suggests It's 44% Undervalued

Key Insights The projected fair value for Janux Therapeutics is US$18.66 based on 2 Stage Free Cash Flow to Equity...

Yahoo | December 27, 2023

Does Janux Therapeutics, Inc. (JANX) Have the Potential to Rally 205.5% as Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 205.5% in Janux Therapeutics, Inc. (JANX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Yahoo | December 1, 2023

Wall Street Analysts See a 220.17% Upside in Janux Therapeutics, Inc. (JANX): Can the Stock Really Move This High?

The consensus price target hints at a 220.2% upside potential for Janux Therapeutics, Inc. (JANX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Yahoo | November 15, 2023

Janux Therapeutics, Inc. (JANX) Loses -34.2% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

The heavy selling pressure might have exhausted for Janux Therapeutics, Inc. (JANX) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

Yahoo | November 10, 2023

Janux Therapeutics Reports Third Quarter 2023 Financial Results and Business Highlights

SAN DIEGO, November 07, 2023--Janux Therapeutics Reports Third Quarter 2023 Financial Results and Business Highlights

Yahoo | November 7, 2023

We're Not Very Worried About Janux Therapeutics' (NASDAQ:JANX) Cash Burn Rate

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

Yahoo | September 23, 2023

10 Healthcare Stocks with Insider Buying

In this article, we will take a look at the 10 healthcare stocks with insider buying. To see more such companies, go directly to 5 Healthcare Stocks with Insider Buying. Investors were processing inflation report on August 10 to find clues on the Federal Reserve’s possible moves. CPI’s growth in July was identical to that […]

Yahoo | August 17, 2023

Wall Street Analysts Think Janux Therapeutics, Inc. (JANX) Could Surge 120.82%: Read This Before Placing a Bet

The average of price targets set by Wall Street analysts indicates a potential upside of 120.8% in Janux Therapeutics, Inc. (JANX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Yahoo | August 10, 2023

Janux Therapeutics, Inc. (JANX) Reports Q2 Loss, Misses Revenue Estimates

Janux Therapeutics, Inc. (JANX) delivered earnings and revenue surprises of 19.23% and 15.44%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | August 8, 2023

Janux Therapeutics Reports Second Quarter 2023 Financial Results and Business Highlights

SAN DIEGO, August 08, 2023--Janux Therapeutics Reports Second Quarter 2023 Financial Results and Business Highlights

Yahoo | August 8, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!